- Report
- January 2022
- 78 Pages
Middle East, Africa
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 121 Pages
North America
From €1432EUR$1,500USD£1,199GBP
- Report
- December 2022
- 355 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- May 2022
- 335 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- June 2021
- 259 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- August 2022
- 14 Pages
Global
From €2381EUR$2,495USD£1,995GBP
- Report
- September 2021
- 14 Pages
Global
From €2381EUR$2,495USD£1,995GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2023
- 394 Pages
Global
From €5726EUR$6,000USD£4,798GBP
- Report
- January 2023
- 303 Pages
United Kingdom
€3397EUR$3,684USD£2,750GBP
- Webinar
- January 2022
- 60 Minutes
Global
From €181EUR$190USD£152GBP
- Report
- March 2021
- 137 Pages
Global
From €4676EUR$4,900USD£3,918GBP
- Report
- February 2021
- 80 Pages
India
From €1136EUR$1,190USD£952GBP
- Report
- January 2021
China
From €2090EUR$2,190USD£1,751GBP
- Report
- July 2020
- 213 Pages
Global, China
From €3054EUR$3,200USD£2,559GBP
- Report
- February 2025
United States
From €1766EUR$1,850USD£1,479GBP

The Coronavirus Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. Diagnostics are also used to monitor the spread of the virus and to track its mutations.
The market is composed of a variety of companies, ranging from large multinationals to small startups. These companies are developing a range of tests, from rapid antigen tests to more complex molecular tests. They are also developing technologies to improve the accuracy and speed of testing, as well as to reduce the cost of testing.
Some of the major players in the Coronavirus Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Other companies in the market include BioMedomics, BioFire Diagnostics, Luminex, and Quidel. Show Less Read more